Literature DB >> 14416537

Application of continuous flow electrophoresis to the study of the blood coagulation proteins. II. The hemophilias (A and B).

J H LEWIS, W R MERCHANT.   

Abstract

Entities:  

Keywords:  BLOOD COAGULATION; HEMORRHAGIC DIATHESIS/blood

Mesh:

Year:  1959        PMID: 14416537      PMCID: PMC441779          DOI: 10.1172/JCI103970

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  7 in total

1.  Differential diagnosis and treatment in hemorrhagic disease.

Authors:  J H LEWIS; P DIDISHEIM
Journal:  AMA Arch Intern Med       Date:  1957-07

2.  Clotting of hemophilic blood with purified platelet cofactor I, platelet factor 3 and threone.

Authors:  W H SEEGERS; R H LANDABURU; R R HOLBURN; L M TOCANTINS
Journal:  Proc Soc Exp Biol Med       Date:  1957-07

3.  Application of continuous flow electrophoresis to the study of the blood coagulation proteins and the fibrinolytic enzyme system. I. Normal human materials.

Authors:  J H LEWIS; D WALTERS; P DIDISHEIM; W R MERCHANT
Journal:  J Clin Invest       Date:  1958-09       Impact factor: 14.808

4.  Nature of the blood clotting mechanisms in hemophilia.

Authors:  S A JOHNSON; R I McCLAUGHRY; W H SEEGERS
Journal:  J Mich State Med Soc       Date:  1955-07

5.  New hemophilia-like disease caused by deficiency of a third plasma thromboplastin factor.

Authors:  R L ROSENTHAL; O H DRESKIN; N ROSENTHAL
Journal:  Proc Soc Exp Biol Med       Date:  1953-01

6.  Hemophilic syndromes and hemophilia.

Authors:  L M TOCANTINS
Journal:  Blood       Date:  1954-03       Impact factor: 22.113

7.  Hemophilia and hemophilia-like diseases caused by deficiencies in plasma thromboplastin factors: anti-hemophilic globulin (AHG), plasma thromboplastin component (PTC) and plasma thromboplastin antecedent (PTA).

Authors:  R L ROSENTHAL
Journal:  Am J Med       Date:  1954-07       Impact factor: 4.965

  7 in total
  1 in total

1.  A circulating anticoagulant in gamma-1A-multiple myeloma: its modification by penicillin.

Authors:  H I Glueck; R Hong
Journal:  J Clin Invest       Date:  1965-11       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.